Cross Cultural Psychiatry »

Herrera, John M., PhD (Eli Lilly and Company, Indianapolis); Lawson, William B., MD, PhD, FAPA (Indiana Univ); Sramek, John J., PharmD (California Clinical Trials, Beverly Hills)

Cross Cultural Psychiatry addresses the question of why different populations respond differently to standard pharmacological treatments by looking not only at the biological mechanisms that underlie differential response but also at the cultural elements; at the illness and its context, and at the patientclinician relationship. In doing so, the volume will provide:

• A unique contribution to this field
• Excellent coverage of the relevant issues, such as the clinical implications of differential drug response
• Both the practical and theoretical angles of the issues discussed
• Detailed investigations of differential responses to individual illnesses, for example schizophrenia and affective disorder

Written by outstanding researchers in the field, Cross Cultural Psychiatry will provide essential information for psychiatrists, psychologists, psychopharmacologists and members of the pharmaceutical industry.

	List of contributors
	Introduction
	Acknowledgments
1	Ethnicity and the Pharmacogenetics of Drug-Metabolizing Enzymes	3
2	Genetic Polymorphism of Drug Oxidation	17
3	Pharmacokinetic Analysis of Ethnic Groups Using Population Methods	37
4	Psychopharmacology in Cross Cultural Psychiatry	45
5	Prescribing for Africans: Some Transcultural Guidelines	53
6	Ethnicity and Psychopharmacology in Latin America	63
7	The Art and Science of Ethnopharmacotherapy	67
8	American Indians and Mental Health: Issues in Psychiatric Assessment and Diagnosis	77
9	Structured Diagnostic Instruments in Cross Cultural Psychiatric Epidemiology: The Experience in Hispanic Communities and Other Groups	87
10	Psychiatric Diagnosis of African Americans	99
11	Review of Neuroleptic Dosage in Different Ethnic Groups	107
12	Treatment of the African-American Patient with Novel Antipsychotic Agents	131
13	Schizophrenia Among Hispanics	139
14	Neuroleptic Dosing in Hispanics and Asian Patients with Schizophrenia	155
15	Treatment-Resistant Schizophrenia in African Americans	165
16	Risperidone in the Treatment of Hispanic Schizophrenic Patients	183
17	Relationship of Ethnicity to the Effects of Antipsychotic Medications	193
18	Antidepressant Response in Ethnic Populations	207
19	Meta-Analysis of Safety of Fluoxetine in Asian Patients	221
20	Ethnicity and Mood Disorders	239
21	A Double-Blind Comparison of Fluoxetine and Amitriptyline in the Treatment of Major Depression with Associated Anxiety ('Anxious Depression')	249
22	Psychiatric Inpatient Care and Ethnic Minority Populations	261
23	The Asian Focus Unit at UCSF: An 18-year Perspective	275
24	Development of a Client-centered Inpatient Service For African Americans	287
25	The Effectiveness of a Culturally Sensitive Milieu on Hospitalized Hispanic Patients	295
26	Anthropological Issues on Ethnic Units	303
27	Gender Differences in Psychotropic Medications	315
28	Gender and Ethnic Differences in the Pharmacogenetics of Psychotropics	323
29	Gender and Response to Antipsychotic Medications	343
30	National Institute of Mental Health: An Update on Women and Minorities in Research	355
31	Interethnic Psychopharmacologic Research in Children and Adolescents	365
32	Psychopharmacology of Children and Adolescents	373
	Index	383